Physiological versus standard sex steroid replacement in young women with premature ovarian failure: effects on bone mass acquisition and turnover
- 16 November 2010
- journal article
- research article
- Published by Wiley in Clinical Endocrinology
- Vol. 73 (6) , 707-714
Abstract
Background The aim of this exploratory study was to establish whether we could improve skeletal health with a physiological regimen of SSR in young women with premature ovarian failure (POF).Patients and Methods In an open‐label randomized controlled crossover trial, 34 women with POF were randomized to 4‐week cycles of pSSR (transdermal oestradiol, 100 μg daily for week 1, 150 μg for weeks 2–4; vaginal progesterone, 200 mg twice daily for weeks 3–4) or standard hormone replacement treatment (sHRT) (oral ethinyloestradiol 30 μg and 1·5 mg norethisterone daily for weeks 1–3, week 4 ‘pill‐free’) for 12 months. Bone mineral density (BMD) was measured by DEXA at study entry and after each 12‐month treatment period. Blood samples for hormones and markers of bone formation (bone alkaline phosphatase, BALP and type I collagen N‐terminal propeptide, PINP) and bone resorption (CrossLaps) were collected pre‐/postwashout and after 3, 6 and 12 months of each treatment.Results Eighteen women, mean 27 (range 19–39) years, completed the study. Both regimens caused similar suppression of LH and FSH. Mean baseline lumbar spine BMD z‐score was −0·89 (95% CI −1·27 to −0·51) and increased by +0·17 (CI +0·07 to +0·27) in response to pSSR (P = 0·003), compared with +0·07 (CI −0·03 to +0·18) during standard HRT (P = 0·2). During pSSR, the increment in lumbar spine BMD z‐score was related positively to oestradiol (r = +0·49, P = 0·04) and inversely to FSH (r = −0·65, P = 0·004). Bone formation markers, BALP and P1NP increased in the pSSR arm (anovaP < 0·001) but decreased in the sHRT arm (P < 0·01). Both treatments suppressed the bone resorption marker, CrossLaps (P < 0·001).Conclusion We conclude that pSSR over 12 months has a beneficial affect on bone mass acquisition on the lumbar spine in women with POF, mediated by increased bone formation and decreased bone resorption.Keywords
This publication has 28 references indexed in Scilit:
- Cardiovascular Effects of Physiological and Standard Sex Steroid Replacement Regimens in Premature Ovarian FailureHypertension, 2009
- Effect of growth hormone and 17β‐oestradiol treatment on metabolism and body composition in girls with Turner syndromeClinical Endocrinology, 2005
- Choice of hormone replacement therapy in young women with ovarian failureClinical Endocrinology, 2001
- Response of Biochemical Markers of Bone Turnover to Hormone Replacement Therapy: Impact of Biological VariabilityJournal of Bone and Mineral Research, 1998
- Gonadal function after bone marrow transplantation for acute leukemia during childhoodThe Journal of Pediatrics, 1997
- Hormone Replacement Therapy in the ElderlyClinical Obstetrics and Gynecology, 1996
- Osteoporosis in Turner's syndrome and other forms of primary amenorrhoeaClinical Endocrinology, 1995
- Influences on skeletal mineralization in children and adolescents: Evidence for varying effects of sexual maturation and physical activityThe Journal of Pediatrics, 1994
- Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyteBritish Journal of Radiology, 1989
- PREDICTION OF OVULATION BY PROGESTERONEThe Lancet, 1981